BioImpact logo

BioImpact

Asia, Yamanashi, Japan, Shinjuku

Description

BioImpact supports the collection of information such as statistical data and effective information transmission centered on research.

Investor Profile

BioImpact has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B rounds (top funding stages).
  • Majority of deals are located in Japan, United States.
  • Strong thematic focus on Information Technology, Biotechnology, Medical.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • Japan (50%)
  • United States (50%)

Industry Focus

  • Information Technology
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BioImpact frequently co-invest with?

ANRI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Merck
Europe, Hessen, Germany, Darmstadt
Co-Investments: 1
Leave a Nest
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Archetype Ventures
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
DNX Ventures
North America, California, United States, San Mateo
Co-Investments: 1

What are some of recent deals done by BioImpact?

Orna Therapeutics

Cambridge, Massachusetts, United States

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BAug 16, 2022
Amount Raised: $221,000,000
Inner Resource

Hongo, Tokyo, Japan

Inner Resource is a cloud purchasing system specialized in research industry.

Information Technology
SeedFeb 13, 2019
Amount Raised: $721,159